Volume 145, Issue 5, Pages e7 (November 2013)

Slides:



Advertisements
Similar presentations
Volume 138, Issue 3, Pages (March 2010)
Advertisements

Volume 129, Issue 5, Pages (November 2005)
Volume 135, Issue 5, Pages e1 (November 2008)
Volume 142, Issue 4, Pages e3 (April 2012)
Volume 143, Issue 2, Pages e8 (August 2012)
Volume 132, Issue 5, Pages (May 2007)
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Volume 140, Issue 2, Pages (February 2011)
Volume 145, Issue 6, Pages e1 (December 2013)
Self-Excising Retroviral Vectors Encoding the Cre Recombinase Overcome Cre- Mediated Cellular Toxicity  Daniel P. Silver, David M. Livingston  Molecular.
Volume 137, Issue 2, Pages e2 (August 2009)
Hepatitis C Virus Infection of Neuroepithelioma Cell Lines
Volume 141, Issue 3, Pages (September 2011)
Volume 143, Issue 2, Pages e1 (August 2012)
Establishment of Endoderm Progenitors by SOX Transcription Factor Expression in Human Embryonic Stem Cells  Cheryle A. Séguin, Jonathan S. Draper, Andras.
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 145, Issue 5, Pages e7 (November 2013)
Volume 150, Issue 1, Pages e4 (January 2016)
Volume 2, Issue 6, Pages (June 2014)
Volume 124, Issue 7, Pages (June 2003)
Volume 134, Issue 1, Pages (January 2008)
Volume 138, Issue 2, Pages (February 2010)
Volume 132, Issue 5, Pages (May 2007)
Zinc Mesoporphyrin Induces Rapid Proteasomal Degradation of Hepatitis C Nonstructural 5A Protein in Human Hepatoma Cells  Weihong Hou, Qing Tian, Jianyu.
Volume 140, Issue 5, Pages (May 2011)
Volume 144, Issue 1, Pages e6 (January 2013)
Volume 138, Issue 7, Pages (June 2010)
Volume 136, Issue 2, Pages (February 2009)
Volume 133, Issue 5, Pages (November 2007)
Volume 143, Issue 2, Pages e8 (August 2012)
Volume 2, Issue 6, Pages (June 2014)
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 132, Issue 7, Pages (June 2007)
Volume 135, Issue 5, Pages e2 (November 2008)
Volume 136, Issue 7, Pages (June 2009)
Volume 127, Issue 1, Pages (July 2004)
Volume 136, Issue 3, Pages (March 2009)
Volume 141, Issue 5, Pages e2 (November 2011)
Volume 12, Issue 6, Pages (June 2013)
Volume 18, Issue 11, Pages (November 2011)
Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus
Volume 131, Issue 6, Pages (December 2006)
Volume 145, Issue 3, Pages e11 (September 2013)
Volume 138, Issue 3, Pages (March 2010)
Volume 5, Issue 3, Pages (March 2009)
EB3 Regulates Microtubule Dynamics at the Cell Cortex and Is Required for Myoblast Elongation and Fusion  Anne Straube, Andreas Merdes  Current Biology 
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 133, Issue 4, Pages (October 2007)
Volume 7, Issue 1, Pages 1-10 (July 2016)
Volume 27, Issue 1, Pages (July 2007)
Volume 4, Issue 5, Pages (May 2015)
Volume 49, Issue 6, Pages (December 2008)
Volume 137, Issue 2, Pages (August 2009)
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Volume 3, Issue 1, Pages (July 2014)
Volume 9, Issue 5, Pages (November 2017)
Volume 9, Issue 5, Pages (November 2017)
Volume 12, Issue 5, Pages (November 2003)
HBL1 Is a Human Long Noncoding RNA that Modulates Cardiomyocyte Development from Pluripotent Stem Cells by Counteracting MIR1  Juli Liu, Yang Li, Bo Lin,
Volume 150, Issue 1, Pages e4 (January 2016)
Volume 5, Issue 4, Pages (October 2015)
Volume 9, Issue 3, Pages (March 2009)
Urtzi Garaigorta, Francis V. Chisari  Cell Host & Microbe 
B7h, a Novel Costimulatory Homolog of B7. 1 and B7
Volume 3, Issue 1, Pages (January 2013)
Volume 9, Issue 5, Pages (November 2017)
Cellular Heterogeneity in the Mouse Esophagus Implicates the Presence of a Nonquiescent Epithelial Stem Cell Population  Aaron D. DeWard, Julie Cramer,
Volume 131, Issue 5, Pages (November 2006)
Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner  Juan Lama, Aram Mangasarian,
Volume 157, Issue 3, Pages e9 (September 2019)
Presentation transcript:

Volume 145, Issue 5, Pages 966-969.e7 (November 2013) Hepatic Cells Derived From Induced Pluripotent Stem Cells of Pigtail Macaques Support Hepatitis C Virus Infection  Marion Sourisseau, Orit Goldman, Wenqian He, Jennifer L. Gori, Hans–Peter Kiem, Valerie Gouon–Evans, Matthew J. Evans  Gastroenterology  Volume 145, Issue 5, Pages 966-969.e7 (November 2013) DOI: 10.1053/j.gastro.2013.07.026 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 MnHep cells support HCV infection. To gauge their capacity to support HCV infection, Huh-7.5 and MnHep cells were challenged with wild-type genotype 2a Jc1 HCVcc. At the indicated hours postinfection (h.p.i.), (A) intracellular and (B) extracellular RNA was quantified by quantitative reverse-transcription polymerase chain reaction. 2′CMA, an HCV polymerase inhibitor, was included in parallel infections to show replication-independent RNA levels. Values represent the absolute number of HCV RNA copies determined relative to a standard curve in relationship to the quantity of total RNA for intracellular samples or volume of supernatant for extracellular samples. (C) At 96 h.p.i., mock or HCV-infected cells, with or without 2′CMA, were immunostained for the HCV E2 glycoprotein (red) and Hoechst counterstained (blue). (D) Infectious HCV in supernatants collected at 48 h.p.i. was quantified by limiting dilution assay on Huh-7.5 cells and expressed as 50% tissue culture infectious dose per milliliter (TCID50/mL). Means and SDs of 3 independent experiments, each performed in triplicate. ***P < .001 (Mann–Whitney test) Gastroenterology 2013 145, 966-969.e7DOI: (10.1053/j.gastro.2013.07.026) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Cellular and viral determinants of MnHep cell HCV entry capacity. MnHep cells transduced to express green fluorescent protein (GFP) alone as a negative control or the indicated HCV cell entry factors were challenged with GLuc expressing (A) genotype 1a H77 HCVpp or (B) genotype 2a Jc1 HCVcc. Infections were performed in parallel with an HCV neutralizing antibody (Anti-E2) or 2'CMA, respectively. GLuc values were measured at 48 h.p.i. for HCVpp or the indicated times for HCVcc, normalized to parallel VSVGpp infections, and set relative to infection of highly permissive Huh-7.5 cells. Three independent experiments, each performed with 6 replicates, are represented, and statistics are relative to GFP alone. Naïve Huh-7.5 and MnHep cells were challenged with mouse CD81 adapted HCVcc, and (C) intracellular and (D) extracellular HCV RNA levels were assayed as described in the preceding text. Three independent experiments were each performed in triplicate. ***P < .001 (Mann–Whitney test). Gastroenterology 2013 145, 966-969.e7DOI: (10.1053/j.gastro.2013.07.026) Copyright © 2013 AGA Institute Terms and Conditions

Supplementary Figure 1 Generation of MnIPSC derived hepatic cells. (A) Illustration of the hepatic differentiation protocol used to generate MnHep cells from MniPSC cells, as described in Supplementary Methods. (B) By day 5 of endoderm differentiation, the majority of cells (86.5%) had developed into definitive endoderm-enriched populations, as gauged by the flow cytometry analysis of coexpression of 2 endodermal markers: CXCR4 and cKIT. On day 5, endoderm-enriched population cells were plated onto gelatin and specified toward the hepatic lineage. On the indicated days of differentiation, cells were fixed and immunostained for (C) the endoderm markers FOXA2 and GATA4 and (D) the hepatic markers HNF4α, α-fetoprotein (AFP), and transthyretin (TTR) and the epithelial marker cytokeratin 18 (CK18). Nuclei of cells were also counterstained with DAPI. Note that virtually all cells express GATA4 and FOXA2 and that most cells are positive for AFP, CK18, and TTR, indicative of an efficient endoderm induction and hepatic specification (200-fold magnification). (E) Relative transcript levels, as determined by qRT-PCR at the indicated days of differentiation, of early hepatic endoderm markers FOXA2, HNF4α, and CK19 decreased over time, while markers for specification and maturation AFP, CK18, CYP3a4, albumin (ALB), α1-antitrypsin (AAT), and E-cadherin increased over time, indicative of maturation of hepatic cells. Levels of the master regulator of hepatic cell fate, HNF4α, remained relatively constant with time. Shown are means and SDs from 3 independent cultures. (F) MnHep cells at differentiation day 12, but not day 0, efficiently internalize acetylated LDL (Alexa Fluor 488–acLDL) (green staining). (G) Periodic acid–Schiff staining of day 9, 12, and 17 hepatic cultures showed increasing glycogen storage (red staining) with time in hepatic cells. (H) The bright field pictures show confluent monolayers with hepatic cell morphology developing at day 12. Gastroenterology 2013 145, 966-969.e7DOI: (10.1053/j.gastro.2013.07.026) Copyright © 2013 AGA Institute Terms and Conditions

Supplementary Figure 2 MnHep cell HCV entry factor expression. At the indicated days of hepatic differentiation, the expression levels of the cellular factors required for HCV cell entry in naïve MnHep cells were gauged by (A) qRT-PCR (means and SDs of n = 3 analysis, normalized to ACTIN); (B) flow cytometry analysis for CD81, occludin, SR-B1, and IgG control (because a suitable antibody to stain MnCLDN1 was not identified, this protein was not analyzed by fluorescence-activated cell sorting), and (C) immunostaining for OCLN. Note that although OCLN transcript levels do not vary greatly, this protein is not detected until 12 days into the differentiation process. (D) The levels of miR-122 were quantified by qRT-PCR from total RNA samples collected at the indicated day of differentiation. (E) Immunoblot with antibodies that bind either GFP, to track transgene expression, or Actin, as a loading control of lysates from naïve MnHep cells or those transduced with lentiviruses to express a fusion protein of GFP and the indicated HCV cell entry factor. Approximate molecular weight (kilodalton) marker positions are indicated to the left, and the predicted size of each expressed protein is marked on the right of each blot. Gastroenterology 2013 145, 966-969.e7DOI: (10.1053/j.gastro.2013.07.026) Copyright © 2013 AGA Institute Terms and Conditions

Supplementary Figure 3 Comparison of OCLN orthologue HCV cell entry functions. (A) The MnOCLN coding sequence was amplified from MnHep cDNA as described in Materials and Methods. The MnOCLN protein sequence had 97.3% identity and 98.7% similarity to human OCLN and 99.8% identity and 99.8% similarity to the Rhesus macaque OCLN protein (only encoded a single alanine-to-valine change in the second transmembrane domain at amino acid position 157). Shown is an alignment of the OCLN second extracellular loop sequences of the indicated species, with amino acid numbering corresponding to the human OCLN sequence and identical and similar amino acids shaded dark and light, respectively. We previously showed that this region contains the determinants for differences in OCLN HCV cell entry factor activity between these species.8 A line above the alignment marks the cluster of residues shown to be most important for species-specific functions. (B) To test OCLN entry factor activities, 786-O cells, which are unable to support HCV cell entry due to insufficient levels of endogenous OCLN,5 were transduced to express either GFP alone or GFP fused to OCLN from the indicated species. These cells were challenged with HCVpp as described in Materials and Methods. Luciferase reporter levels, assayed 2 days postinfection, are shown normalized to parallel infections with VSVGpp, which infect nearly all mammalian cells and thus help control for cell number variations, and set relative to infections of cells expressing human OCLN. Mean and SE of 2 independent experiments, each performed in quadruplicate, are shown. (C) Immunoblots for either GFP or actin of lysates from 786-O cell populations transduced to express the indicated transgenes. Approximate molecular weight (kilodaltons) marker positions are indicated to the left of each blot. **P < .01 (Mann–Whitney test). Gastroenterology 2013 145, 966-969.e7DOI: (10.1053/j.gastro.2013.07.026) Copyright © 2013 AGA Institute Terms and Conditions

Supplementary Figure 4 Comparison of CD81 orthologue HCV cell entry functions. (A) The MnCD81 coding sequence was amplified from MnHep cDNA as described in Materials and Methods. Although this sequence shared 98.3% identity and 99.2% similarity with the human CD81 sequence, it has 100% identity with the Rhesus macaque and African green monkey CD81 proteins, the latter of which was previously shown to mediate HCV cell entry less efficiently than the human version due to diminished HCV E2 glycoprotein binding.16 Shown in this figure are the only 4 amino acid differences between these sequences, all occurring in the CD81 large extracellular loop. The amino acid positions are labeled above the sequence, and identical and similar amino acids are shaded dark and light, respectively. (B) HCVpp infectivity (normalized to parallel VSVGpp infections and relative to infections of cells expressing human OCLN) of HepG2 cells, which normally do not support HCV cell entry due to a lack of endogenous CD81, expressing either GFP alone or GFP fused to the CD81 protein from the indicated species. Mean and SE of 2 independent experiments, each performed in quadruplicate, are shown. (C) Immunoblots for either the GFP or actin of lysates from HepG2 cell populations transduced to express the indicated transgenes. Approximate molecular weight (kilodalton) marker positions are indicated to the left of each blot. **P < .01 (Mann–Whitney test). Gastroenterology 2013 145, 966-969.e7DOI: (10.1053/j.gastro.2013.07.026) Copyright © 2013 AGA Institute Terms and Conditions